2024 Fellows and Honorary Fellows announced

We are delighted to announce our new Fellows and Honorary Fellows for 2024. 40 Fellows have been elected and 13 Honorary Fellowships awarded.

Our Fellows and Honorary Fellows play an incredibly important role in the Society. Through their work, they further all disciplines of pharmacology in the discovery, development and use of medicines. And through their leadership, and contribution to Society life, they inspire and support members at earlier stages of their career or study.
 
President of the Society, Professor Sir Mark Caulfield, said: “The individuals elected this year reflect the broad expertise currently advancing pharmacology across academia, clinical care and industry. It also reflects the diversity within the Society’s membership: there is a 60/40 gender split and over 34% are international. We have also elected two early career researchers to Fellowship.
 
Please join me in congratulating our newly elected Fellows and Honorary Fellows”.
 
Honorary Fellowships
 
Honorary Fellows are elected for life in recognition of sustained excellence and leadership in science, healthcare, and public service.

• Professor Amrita Ahluwalia, Queen Mary, University of London
• Dr Steve Alexander, University of Nottingham
• Professor Ingolf Cascorbi, University of Kiel
• Professor Jamie Coleman, University of Birmingham
• Dr Michael Jarvis, ASPET
• Professor Eamonn Kelly, University of Bristol
• Professor Luke O’Neill, Trinity College Dublin
• Dr Rachel Quinn, Academy of Medical Sciences
• Steve Rees, AstraZeneca
• Professor Peter Sever, Imperial College London
• Professor Edith Sim, University of Oxford
• Professor JoAnn Trejo, University of California, San Diego
• Professor Ijeoma Uchegbu, University College London

Find out more about Honorary Fellowship

Fellowships

Fellows have demonstrated distinction and peer recognition in pharmacology, through their work, publication and presentation of research, leadership, and contribution to Society life.

• Dr José-Antonio Arias-Montaño, Cinvestav
• Dr Chris Bailey, University of Bath
• Dr Alexis Bailey, St George’s, University of London
• Dr Malcolm Begg, Apollo Therapeutics
• Dr Gavin Bennett, Bicycle Therapeutics
• Professor Alan Boyd, Boyd Consultants Ltd
• Professor Vincenzo Brancaleone, University of Basilicata
• Dr Hilary Carswell, University of Strathclyde
• Professor Zamri Chik, University of Malaya
• Dr Caroline Copeland, King's College London
• Professor Craig Daly, University of Glasgow
• Professor Asita De Silva, University of Kelaniya
• Dr Lindsey Ferrie, Newcastle University
• Dr James Fullerton, University of Oxford
• Dr Stephen Getting, University of Westminster
• Dr Geert Groeneveld, Centre for Human Drug Research
• Dr Sam Groom, University of Manchester
• Dr Patrick Hadoke, University of Edinburgh
• Dr Matthew Harper, University of Cambridge
• Dr Martin Hawes, University of Surrey
• Professor Martina Hennessy, Trinity College Dublin
• Dr Ashish Kakkar, Postgraduate Institute of Medical Education and Research
• Professor Carl Kirkpatrick, Monash University
• Dr Stefanie Lip, University of Glasgow
• Dr Yu-ling Ma, University of Oxford
• Dr Emma Magavern, Queen Mary, University of London
• Dr Anna Morgan, Kingston, University of London
• Dr Fiona Murray, University of Aberdeen
• Dr Janet Nicholson, Boehringer Ingelheim
• Professor John Rudd, Chinese University of Hong Kong
• Professor Ulf Simonsen, Aarhus University
• Dr Sharon Smith, DevelRx
• Dr Katarzyna Starowicz, Institute of Pharmacology
• Dr Barbara Stefanska, University of British Columbia
• Dr Jennifer Stott, St Georges, University of London
• Dr Lisa Stott, Nxera Pharma
• Dr Richard Turner, University of Liverpool
• Professor Catriona Waitt, University of Liverpool
• Dr Sarah Walsh, Robert Gordon University
• Dr Cafer Yildirim, Ankara University 

Find out more about Fellowship.